Daily Archives: December 13, 2007

Chalk Up Yet Another Multiple Approvable Letter – This Time for Neurocrine

Neurocrine Biosciences has announced that they received a second approvable letter from the FDA for their product indiplon for the treatment of insomnia.  According to the company release: On May 15, 2006, the Company received an action letter from the … Continue reading

Posted in FDA Policy | 1 Comment